Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US17030504Application Date: 2020-09-24
-
Publication No.: US11453661B2Publication Date: 2022-09-27
- Inventor: Masahiro Ito , Hideyuki Sugiyama , Takeshi Yamamoto , Keiko Kakegawa , Jinxing Li , Junsi Wang , Takahito Kasahara , Masato Yoshikawa
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JPJP2019-177815 20190927
- Main IPC: C07D413/14
- IPC: C07D413/14 ; A61P25/28 ; C07D413/10
Abstract:
The present invention provides a heterocyclic compound having a HDAC6 inhibitory action, which is useful for the treatment of central nervous system diseases including neurodegenerative diseases, and the like, and a medicament comprising the compound.
The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof.
The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt thereof.
Public/Granted literature
- US20210094944A1 HETEROCYCLIC COMPOUND Public/Granted day:2021-04-01
Information query
